Brim Analytics is driving to the next cure, faster with a democratized AI-guided chart abstraction system. Chart abstraction is the process of converting unstructured clinical notes into structured data, an essential task across healthcare, including clinical trial matching, academic research, registries for cancer and heart disease, and many more. Brim is an AI-guided tool for chart abstraction that prioritizes privacy and security, creates traceability of data, and is dramatically faster than human curators alone.

Faster, smarter chart abstraction to streamline clinical workflows, pre-screen clinical trials, accelerate retrospective research, and more.

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

Brim enables fast and flexible abstraction of structured data from unstructured notes.

• Fast Abstraction. AI-guided generation saves 80% of the time relative to manual abstraction with comparable accuracy.
• Scalable. Abstract data at scale, rather than note-by-note.
• Flexible. Easily iterate on the fields you derive as you learn or your process evolves.
• EHR-agnostic. Import and export via a standard format.

• Privacy and Security first. Brim is fully secure, and we do not train on your data. You can implement in your institution's cloud environment, or in a single-tenant deployment. Leverage your institution's LLM endpoint. Brim supports Open AI, Azure Open AI, Bedrock, and other LLMs to get the newest foundational models without adding another vendor.
• Built for researchers and abstractors. Purpose-built interface for abstraction helps humans move faster and improves the accuracy of abstracted data.
• Domain flexibility. Brim has been used for projects in cancer research, clinical trials, orthopedic injuries, and many more. Brim optimizes variables for your project based on your feedback, improving abstraction in real time.

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement